📊Executive Summary

MIT has developed a new ingestible electronic pill that utilizes biodegradable radio-frequency antennas to confirm medication adherence. This innovation aims to improve patient compliance, particularly for critical health conditions. The technology allows the pill to communicate its ingestion status to external devices, enhancing remote monitoring capabilities. The materials used are safe and bioresorbable, minimizing long-term health risks. As this technology progresses towards human trials, it could significantly impact the medical device market and procurement strategies for healthcare providers....